Indefinite Delivery Contract SPE2DB24D2217

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp's Corporate Office Division worth up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Under this contract, Amerisourcebergen provides specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. This IDC enables the DLA to efficiently procure essential medical commodities for military treatment programs and facilities globally, supporting the agency's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, is a well-established supplier of pharmaceuticals and medical supplies to the federal government, particularly the Department of Defense and the Department of Veterans Affairs. The company's expertise in pharmaceutical distribution and extensive supply chain network allows it to efficiently manage the complex logistics of supplying critical medical products to government facilities across the country and overseas. Amerisourcebergen has received numerous federal contract awards for supplying specific pharmaceutical products and medical supplies, highlighting its competitive position in the federal pharmaceutical supply market.